Multidrug-resistantMycobacterium tuberculosis, Bangui, Central African Republic
Open Access
- 1 September 2006
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 12 (7) , 1454-1456
- https://doi.org/10.3201/eid1209.060361
Abstract
We investigated multidrug-resistant (MDR) Mycobacterium tuberculosis strains in Bangui, Central African Republic. We found 39.6% with the same spoligotype and synonymous single nucleotide polymorphism in the mutT1 gene. However, strains had different rpoB mutations responsible for rifampin resistance. MDR strains in Bangui may emerge preferentially from a single, MDR-prone family.Keywords
This publication has 14 references indexed in Scilit:
- Tuberculosis due to Resistant Haarlem Strain, TunisiaEmerging Infectious Diseases, 2005
- Drug-Susceptible Mycobacterium tuberculosis Beijing Genotype Does Not Develop Mutation-Conferred Resistance to Rifampin at an Elevated RateJournal of Clinical Microbiology, 2003
- The Burden of Drug‐Resistant Tuberculosis and Mechanisms for Its ControlAnnals of the New York Academy of Sciences, 2001
- Determinants of drug-resistant tuberculosis: analysis of 11 countries.2001
- Mycobacterium tuberculosisBeijing Genotype Strains Associated with Febrile Response to TreatmentEmerging Infectious Diseases, 2001
- Global Trends in Resistance to Antituberculosis DrugsNew England Journal of Medicine, 2001
- High Rate of Tuberculosis Reinfection during a Nosocomial Outbreak of Multidrug-Resistant Tuberculosis Caused by Mycobacterium bovis Strain BClinical Infectious Diseases, 2001
- The Global Problem of Multidrug-Resistant TuberculosisJAMA, 2000
- Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 updateTubercle and Lung Disease, 1998
- Origin and Interstate Spread of a New York City Multidrug-Resistant Mycobacterium tuberculosis Clone FamilyJAMA, 1996